Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.1 to v3.0.2 and removed the old tag and a Back to Top link, signaling a routine version bump with minor UI cleanup.
    Difference
    0.6%
    Check dated 2025-09-14T00:08:08.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T17:49:13.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings. This indicates a shift towards a more streamlined presentation of study-related information.
    Difference
    32%
    Check dated 2025-08-30T15:26:29.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T08:55:40.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T06:40:52.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    5%
    Check dated 2025-08-02T02:55:58.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.